Globus Medical (GMED) Cash from Financing Activities (2011 - 2026)

Globus Medical (GMED) has reported Cash from Financing Activities for 16 consecutive years, with -$134.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Financing Activities fell 439.34% year-over-year to -$134.5 million; the trailing twelve-month figure through Jun 2026 stood at -$135.1 million (up 76.74% YoY), and the FY2025 full-year result was -$679.2 million, down 2352.2% from the prior year.
• Cash from Financing Activities fell to -$134.5 million in Q2 2026 per GMED's latest filing, from $18.2 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $59.7 million in Q4 2024 and bottomed at -$635.4 million in Q1 2025.
• Historically, Cash from Financing Activities has averaged -$64.7 million across 5 years, with a median of $2.2 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities jumped 1428.54% in 2022, then sank 4036.09% in 2024.
• Over 5 years, Cash from Financing Activities stood at $13.6 million in 2022, then sank by 1845.79% to -$237.3 million in 2023, then jumped by 125.18% to $59.7 million in 2024, then sank by 77.88% to $13.2 million in 2025, then sank by 1117.75% to -$134.5 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$134.5 million, $18.2 million, and $13.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.